Cite Filings / AQST / 0001950047-26-009530

Feed Companies Filings Check

Sign in

144

Sale of Securities

Aquestive Therapeutics, Inc. Filed 2026-09-15 Acc 0001950047-26-009530

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2026-09-17 8-K Regulation FD disclosure · Other events
2026-09-16 4 President and CEO sold 25,000 shares at $4.82 ($120,488)
2026-09-15 144 Sale of Securities
2026-09-11 4 Chief Commercial Officer sold 8,750 shares at $5.22 ($45,675)
2026-09-10 4 Chief People Officer acquired 2,293 shares (option exercise)
2026-09-09 144 Sale of Securities
2026-09-09 4 President and CEO acquired 91,743 shares (option exercise)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…